MTOR and colorectal carcinoma: Wild-type p53 is known to restrain mTOR signaling and support autophagy, yet how TP53 loss integrates metabolic rewiring with immune suppression in MSS CRC-especially with protein- and phosphosite-level validation-remains incompletely defined.